| Produktname | Tesofensine |
|---|---|
| CAS-Nummer | 402856-42-2 |
| Molekülformel | C17H19Cl2NO |
| Molekulargewicht | 324.24 |
| Aussehen | Weißes bis cremefarbenes kristallines Pulver |
| Analyse (HPLC) | ≥98% |
| Trocknungsverlust | ≤0,5% |
| Verbrennungsrückstand | ≤0,1% |
| Schwermetalle | ≤ 10 ppm |
| Schmelzpunkt | 190-194°C |
Brauchst du Hilfe? Kontaktieren Sie unser Team

Tesofensine, NS-2330, 2-[(3,4-Dichlorophenyl)methyl]-4-(1H-indol-2-yl)-1,3-oxazolidine
Tesofensine is shaking up the weight-management scene. It’s a triple monoamine reuptake inhibitor that targets dopamine, norepinephrine, and serotonin — a triple-action approach that sets it apart from single-pathway ingredients. Early studies show it can drive significant weight loss, making it a hot candidate for next-gen anti-obesity formulations.
For manufacturers, that means an ingredient with serious science behind it. We supply tesofensine as a high-purity crystalline powder, every batch shipped with a full COA, flexible from 1 kg trial runs to bulk container orders, and ready for worldwide delivery.